BRIGHTSPRING HEALTH SERVICES (BTSG) Stock Fundamental Analysis
USA - NASDAQ:BTSG - US10950A1060 - Common Stock
33.49 USD
+0.44 (+1.33%)
34.27 USD
+0.78 (+2.33%)
Taking everything into account, BTSG scores 4 out of 10 in our fundamental rating. BTSG was compared to 100 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of BTSG get a neutral evaluation. Nothing too spectacular is happening here. BTSG is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year BTSG was profitable.
BTSG had a positive operating cash flow in the past year.
In multiple years BTSG reported negative net income over the last 5 years.
Of the past 5 years BTSG 4 years had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 2.14%, BTSG perfoms like the industry average, outperforming 57.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 7.13%, BTSG is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
With a Return On Invested Capital value of 4.68%, BTSG perfoms like the industry average, outperforming 54.00% of the companies in the same industry.
BTSG had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.40%.
The 3 year average ROIC (3.45%) for BTSG is below the current ROIC(4.68%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.14% | ||
| ROE | 7.13% | ||
| ROIC | 4.68% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
1.3 Margins
BTSG has a Profit Margin of 1.04%. This is comparable to the rest of the industry: BTSG outperforms 56.00% of its industry peers.
BTSG has a Operating Margin (2.15%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BTSG has grown nicely.
BTSG has a Gross Margin of 12.30%. This is in the lower half of the industry: BTSG underperforms 70.00% of its industry peers.
BTSG's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.15% | ||
| PM (TTM) | 1.04% | ||
| GM | 12.3% |
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BTSG is destroying value.
The number of shares outstanding for BTSG has been increased compared to 1 year ago.
The number of shares outstanding for BTSG has been increased compared to 5 years ago.
Compared to 1 year ago, BTSG has an improved debt to assets ratio.
2.2 Solvency
BTSG has an Altman-Z score of 3.25. This indicates that BTSG is financially healthy and has little risk of bankruptcy at the moment.
BTSG has a better Altman-Z score (3.25) than 66.00% of its industry peers.
BTSG has a debt to FCF ratio of 9.17. This is a negative value and a sign of low solvency as BTSG would need 9.17 years to pay back of all of its debts.
BTSG has a Debt to FCF ratio (9.17) which is comparable to the rest of the industry.
BTSG has a Debt/Equity ratio of 1.36. This is a high value indicating a heavy dependency on external financing.
BTSG has a worse Debt to Equity ratio (1.36) than 66.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.36 | ||
| Debt/FCF | 9.17 | ||
| Altman-Z | 3.25 |
ROIC/WACC0.5
WACC9.28%
2.3 Liquidity
A Current Ratio of 1.79 indicates that BTSG should not have too much problems paying its short term obligations.
BTSG has a Current ratio of 1.79. This is in the better half of the industry: BTSG outperforms 68.00% of its industry peers.
A Quick Ratio of 1.38 indicates that BTSG should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.38, BTSG perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 117.02% over the past year.
Looking at the last year, BTSG shows a quite strong growth in Revenue. The Revenue has grown by 17.23% in the last year.
Measured over the past years, BTSG shows a very strong growth in Revenue. The Revenue has been growing by 20.01% on average per year.
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
3.2 Future
BTSG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.52% yearly.
The Revenue is expected to grow by 12.46% on average over the next years. This is quite good.
EPS Next Y85.44%
EPS Next 2Y54.69%
EPS Next 3Y43.24%
EPS Next 5Y38.52%
Revenue Next Year12.92%
Revenue Next 2Y13.3%
Revenue Next 3Y13.01%
Revenue Next 5Y12.46%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 32.83, BTSG can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as BTSG.
Compared to an average S&P500 Price/Earnings ratio of 26.51, BTSG is valued a bit more expensive.
A Price/Forward Earnings ratio of 25.45 indicates a quite expensive valuation of BTSG.
BTSG's Price/Forward Earnings is on the same level as the industry average.
BTSG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.53.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.83 | ||
| Fwd PE | 25.45 |
4.2 Price Multiples
BTSG's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BTSG indicates a somewhat cheap valuation: BTSG is cheaper than 63.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.49 | ||
| EV/EBITDA | 18.49 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BTSG's earnings are expected to grow with 43.24% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y54.69%
EPS Next 3Y43.24%
5. Dividend
5.1 Amount
No dividends for BTSG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
33.49
+0.44 (+1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners70.16%
Inst Owner Change0.11%
Ins Owners2.57%
Ins Owner Change-4.52%
Market Cap5.93B
Revenue(TTM)12.41B
Net Income(TTM)129.59M
Analysts84.21
Price Target33.11 (-1.13%)
Short Float %17.1%
Short Ratio4.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.94%
Min EPS beat(2)26.26%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)40.55%
Min EPS beat(4)-2.7%
Max EPS beat(4)97.01%
EPS beat(8)5
Avg EPS beat(8)26.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.23%
Min Revenue beat(2)3.22%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)3.24%
Revenue beat(8)6
Avg Revenue beat(8)2.96%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.34%
PT rev (3m)15.49%
EPS NQ rev (1m)9.76%
EPS NQ rev (3m)24.14%
EPS NY rev (1m)8.14%
EPS NY rev (3m)19.16%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)1.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.83 | ||
| Fwd PE | 25.45 | ||
| P/S | 0.48 | ||
| P/FCF | 21.49 | ||
| P/OCF | 16.99 | ||
| P/B | 3.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.49 |
EPS(TTM)1.02
EY3.05%
EPS(NY)1.32
Fwd EY3.93%
FCF(TTM)1.56
FCFY4.65%
OCF(TTM)1.97
OCFY5.89%
SpS70.07
BVpS10.27
TBVpS-6.06
PEG (NY)0.38
PEG (5Y)N/A
Graham Number15.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.14% | ||
| ROE | 7.13% | ||
| ROCE | 5.92% | ||
| ROIC | 4.68% | ||
| ROICexc | 4.83% | ||
| ROICexgc | 14.34% | ||
| OM | 2.15% | ||
| PM (TTM) | 1.04% | ||
| GM | 12.3% | ||
| FCFM | 2.22% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexgc growth 3Y-9.4%
ROICexgc growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.36 | ||
| Debt/FCF | 9.17 | ||
| Debt/EBITDA | 5.55 | ||
| Cap/Depr | 40.71% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 1.44 | ||
| Cash Conversion | 78.31% | ||
| Profit Quality | 213.06% | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.25 |
F-Score7
WACC9.28%
ROIC/WACC0.5
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
EPS Next Y85.44%
EPS Next 2Y54.69%
EPS Next 3Y43.24%
EPS Next 5Y38.52%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
Revenue Next Year12.92%
Revenue Next 2Y13.3%
Revenue Next 3Y13.01%
Revenue Next 5Y12.46%
EBIT growth 1Y36.15%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year60.02%
EBIT Next 3Y26.18%
EBIT Next 5Y28%
FCF growth 1Y324.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y820.28%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%
BRIGHTSPRING HEALTH SERVICES / BTSG FAQ
Can you provide the ChartMill fundamental rating for BRIGHTSPRING HEALTH SERVICES?
ChartMill assigns a fundamental rating of 4 / 10 to BTSG.
What is the valuation status for BTSG stock?
ChartMill assigns a valuation rating of 4 / 10 to BRIGHTSPRING HEALTH SERVICES (BTSG). This can be considered as Fairly Valued.
How profitable is BRIGHTSPRING HEALTH SERVICES (BTSG) stock?
BRIGHTSPRING HEALTH SERVICES (BTSG) has a profitability rating of 4 / 10.
What is the expected EPS growth for BRIGHTSPRING HEALTH SERVICES (BTSG) stock?
The Earnings per Share (EPS) of BRIGHTSPRING HEALTH SERVICES (BTSG) is expected to grow by 85.44% in the next year.